Introduction of Routine Postoperative PET/CT prior to Adjuvant Head and Neck Radiation Therapy

P.T. Courtney,J. Juarez,E.Y. Liu,L.W. Chau,L. Kabarame,M.L. Steinberg,R.K. Chin,R.R. Savjani

DOI: https://doi.org/10.1016/j.ijrobp.2024.01.073

IF: 8.013

2024-04-01

International Journal of Radiation Oncology*Biology*Physics

Abstract:Purpose/Objective(s) Routine clinical practice does not include postoperative positron emission tomography (PET)/CT prior to postoperative radiation therapy (PORT) for head and neck cancer. Besides logistical challenges in obtaining postoperative PET/CT within six to eight weeks after surgery, interpreting PET/CT findings in the postoperative setting can also be difficult. However, given the potential for residual or rapidly recurrent disease, postoperative PET/CT may help identify the need for additional diagnostic evaluation or alter adjuvant therapy. There are limited data evaluating the utility of postoperative PET/CT prior to PORT for head and neck cancer. We sought to evaluate the use and clinical relevance of postoperative PET/CT prior to PORT. Materials/Methods In this retrospective, single-institution cohort study, we identified patients with head and neck cancer between January 1, 2013 and April 1, 2023 who received a postoperative PET/CT prior to PORT. We extracted electronic medical record data supplemented with manual chart review to collect patient and disease-related information. We measured the rates of clinical management alterations, defined as changes in radiation treatment plans (such as boosting or inclusion of new targets), additional diagnostic workup, changes in systemic therapy plans, or additional surgery, as a result of postoperative PET/CT findings. Results The cohort included 133 patients who received a postoperative PET/CT prior to PORT. The mean age at diagnosis was 65 years (standard deviation: 15 years) and 90 (67.2%) were male. Regarding primary site, 34 (25.6%) were oral cavity, 21 (15.8%) were oropharynx, and 78 (58.6%) were other sites including sinonasal, salivary gland, skin, and thyroid. The mean time from surgery to postoperative PET was 37 days (standard deviation: 24 days), and the mean time from postoperative PET/CT to start of PORT was 20 days (standard deviation: 22 days). A total of 84 (63.2%) and 52 (39.0%) of patients started radiation more than 6 and 8 weeks after surgery, respectively. A total of 48 (36.1%) patients experienced a change in management as a result of the PET/CT findings: 44 (91.7%) had a change in radiation plan; 15 (31.2%) underwent additional diagnostic workup; 9 (18.8%) had a change in systemic therapy plan; and 2 (4.2%) underwent additional surgery. Conclusion In patients with head and neck cancer who received postoperative PET/CT prior to PORT, a meaningful proportion underwent additional diagnostic evaluation and/or experienced an alteration in adjuvant therapy because of the PET/CT findings. To our knowledge, this series represents one of the largest to date. Future research will seek to identify those who are most likely to benefit from a postoperative PET/CT and determine whether a normal PET/CT safely allows for delaying the start of radiation, for example to provide additional time for wound healing or accommodate patient logistical challenges.

oncology,radiology, nuclear medicine & medical imaging